Proteomics International Laboratories Limited Stock
Equities
PIQ
AU000000PIQ0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.095 AUD | +0.46% | +0.46% | +22.35% |
Mar. 25 | Proteomics International Signs Agreement with University of Oxford for Endometriosis Study | MT |
Mar. 19 | Proteomics Says PromarkerD's US Launch Delayed | MT |
Sales 2024 * | 2.8M 1.83M | Sales 2025 * | 5.9M 3.85M | Capitalization | 143M 93.62M |
---|---|---|---|---|---|
Net income 2024 * | -7M -4.57M | Net income 2025 * | -5M -3.27M | EV / Sales 2024 * | 49.2 x |
Net cash position 2024 * | 5.7M 3.72M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 24.3 x |
P/E ratio 2024 * |
-19.6
x | P/E ratio 2025 * |
-26.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.87% |
1 day | +0.46% | ||
1 week | +0.46% | ||
Current month | -4.78% | ||
1 month | +1.39% | ||
3 months | +19.02% | ||
6 months | +21.67% | ||
Current year | +22.35% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 14-06-08 | |
Jacqueline Gray
DFI | Director of Finance/CFO | - | 21-07-11 |
Kirsten Peters
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul House
BRD | Director/Board Member | - | 17-11-21 |
Robyn Elliott
BRD | Director/Board Member | 63 | 21-11-15 |
Founder | - | 14-06-08 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.095 | +0.46% | 96,997 |
24-04-24 | 1.09 | +0.46% | 65,471 |
24-04-23 | 1.085 | -2.25% | 161,939 |
24-04-22 | 1.11 | +1.83% | 165,972 |
24-04-19 | 1.09 | -2.68% | 156,209 |
Delayed Quote Australian S.E., April 26, 2024 at 01:22 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+22.35% | 93.47M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PIQ Stock